Abstract
Bone disease in long-term survivors after gastric cancer resection has received little research attention. This study aimed to investigate bone health after curative resection of gastric cancer and the consequences of high-dose vitamin D supplementation in patients with low levels of 25-(OH)-vitamin D. Disease-free patients at least 24 months after gastric cancer resection represented the study cohort. Serum markers of bone metabolism were assessed at baseline and at 3 and 12 months. Bone mineral density and presence of fractures were assessed by X-ray at baseline. Patients with 25-(OH)-vitamin D ≤30 ng/mL at baseline received 16,000 IU of vitamin D3 every 10 days during the 1-year follow-up. Forty patients were included in the study. Mean time from surgery was 48.9 (24–109) months. Vitamin D insufficiency and secondary hyperparathyroidism were observed in 38 and 20 patients, respectively. Densitometry showed osteoporosis in 14 women and seven men and prevalent fractures in 12 women and six men at baseline. After 3 months of vitamin D supplementation, 35 patients reached values of 25-(OH)-vitamin D over 30 ng/mL. After 12 months, 38 patients were in the normal range of 25-(OH)-vitamin D. At the same time, iPTH levels and markers of bone turnover (C-terminal cross-linked telopeptide of type-I collagen, serum concentrations of bone-specific alkaline phosphatase and osteocalcin) significantly decreased after vitamin D intervention. Oral administration of high doses of vitamin D is easily implemented and restored 25-(OH)-vitamin D and iPTH values, which are frequently disturbed after gastric cancer resection.
Similar content being viewed by others
References
Noh SH, Park SR, Yang HK, Chung HC, Chung IJ, Kim SW, Kim HH, Choi JH, Kim HK, Yu W, Lee JI, Shin DB, Ji J, Chen JS, Lim Y, Ha S, Bang YJ, CLASSIC trial investigators (2014) Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial. Lancet Oncol 15:1389–1396
Heaney RP (2013) Health is better at serum 25(OH)D above 30 ng/mL. J Steroid Biochem Mol Biol 136:224–228
Coleman R, Body JJ, Aapro M, Hadji P, Herrstedt J, Group EGW (2014) Bone health in cancer patients: ESMO clinical practice guidelines. Ann Oncol 25:iii124–iii137
Nicolaysen R, Ragard R (1955) The calcium and phosphorus metabolism in gastrectomized patients. Scand J Clin Lab Invest 7:298–299
Heiskanen JT, Kroger H, Paakkonen M, Parviainen MT, Lamberg-Allardt C, Alhava E (2001) Bone mineral metabolism after total gastrectomy. Bone 28:123–127
Bisballe S, Eriksen EF, Melsen F, Mosekilde L, Sorensen OH, Hessov I (1991) Osteopenia and osteomalacia after gastrectomy: interrelations between biochemical markers of bone remodelling, vitamin D metabolites, and bone histomorphometry. Gut 32:1303–1307
Glatzle J, Piert M, Meile T, Besenthal I, Schafer JF, Konigsrainer A, Zittel TT (2005) Prevalence of vertebral alterations and the effects of calcium and vitamin D supplementation on calcium metabolism and bone mineral density after gastrectomy. Br J Surg 92:579–585
Krause M, Keller J, Beil B, van Driel I, Zustin J, Barvencik F, Schinke T, Amling M (2015) Calcium gluconate supplementation is effective to balance calcium homeostasis in patients with gastrectomy. Osteoporosis Int 26:987–995
Lim JS, Lee JI (2011) Prevalence, pathophysiology, screening and management of osteoporosis in gastric cancer patients. J Gastric Cancer 11:7–15
Lim JS, Kim SB, Bang HY, Cheon GJ, Lee JI (2007) High prevalence of osteoporosis in patients with gastric adenocarcinoma following gastrectomy. World J Gastroenterol 13:6492–6497
Gonzalez-Macias J, Del Pino-Montes J, Olmos JM, Nogues X, en nombre de la Comision de Redaccion de las Guias de Osteoporosis de la SEIOMM (2015) Clinical practice guidelines for posmenopausal, glucocorticoid-induced and male osteoporosis. Spanish Society for Research on Bone and Mineral Metabolism (3rd updated version 2014). Rev Clin Esp 215:515–526
Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148
Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. In. Geneva: World Health Organization. Osteoporos Int 4:368–381
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine Society (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930
Moyer VA, LeFevre ML, Siu AL (2013) Vitamin D and calcium supplementation to prevent fractures in adults. Ann Intern Med 159:856–857
Ross AC (2011) The 2011 report on dietary reference intakes for calcium and vitamin D. Public Health Nutr 14:938–939
NIH Consensus Development Panel on Osteoporosis Prevention D, Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785–795
Lustberg MB, Reinbolt RE, Shapiro CL (2012) Bone health in adult cancer survivorship. J Clin Oncol 30:3665–3674
Stava CJ, Jimenez C, Hu MI, Vassilopoulou-Sellin R (2009) Skeletal sequelae of cancer and cancer treatment. J Cancer Surviv 3:75–88
Coates PS, Fernstrom JD, Fernstrom MH, Schauer PR, Greenspan SL (2004) Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J Clin Endocrinol Metab 89:1061–1065
American Gastroenterological Association (2003) American Gastroenterological Association medical position statement: guidelines on osteoporosis in gastrointestinal diseases. Gastroenterology 124:791–794
Prieto-Alhambra D, Servitja S, Javaid MK, Garrigos L, Arden NK, Cooper C, Albanell J, Tusquets I, Diez-Perez A, Nogues X (2012) Vitamin D threshold to prevent aromatase inhibitor-related bone loss: the B-ABLE prospective cohort study. Breast Cancer Res Treat 133:1159–1167
Lanzarini E, Nogues X, Goday A, Benaiges D, de Ramon M, Villatoro M, Pera M, Grande L, Ramon JM (2015) High-dose Vitamin D supplementation is necessary after bariatric surgery: a prospective 2-year follow-up study. Obes Surg 25:1633–1638
Baek KH, Jeon HM, Lee SS, Lim DJ, Oh KW, Lee WY, Rhee EJ, Han JH, Cha BY, Lee KW, Son HY, Kang SK, Kang MI (2008) Short-term changes in bone and mineral metabolism following gastrectomy in gastric cancer patients. Bone 42:61–67
Bischoff-Ferrari HA, Dawson-Hughes B, Orav EJ, Staehelin HB, Meyer OW, Theiler R, Dick W, Willett WC, Egli A (2016) Monthly high-dose vitamin d treatment for the prevention of functional decline: a randomized clinical trial. JAMA Intern Med 176:175–183
Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ (2003) Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77:204–210
Iwamoto J, Uzawa M, Sato Y, Takeda T, Matsumoto H (2010) Effect of alendronate on bone mineral density and bone turnover markers in post-gastrectomy osteoporotic patients. J Bone Miner Metab 28:202–208
Acknowledgements
The authors wish to acknowledge Joan Sancho, MD, for expert help in the statistical analysis, and Elaine Lilly, PhD, for English language editing.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None to be disclosed by any of the authors.
About this article
Cite this article
Climent, M., Pera, M., Aymar, I. et al. Bone health in long-term gastric cancer survivors: A prospective study of high-dose vitamin D supplementation using an easy administration scheme. J Bone Miner Metab 36, 462–469 (2018). https://doi.org/10.1007/s00774-017-0856-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00774-017-0856-1